Ultragenyx Pharmaceutical Inc (RARE)
Industry Biotechnology
This stock can be held in an Investment ISA and an Investment Account
Sell
$31.00
Buy
$44.10
$1.16 (+3.21%)
Ultragenyx Pharmaceutical Inc is biopharmaceutical company. It is engaged identification, acquisition, development and commercialization of novel products for treatment of rare & ultra-rare diseases, with a focus on debilitating genetic diseases.
Prices updated at 21 May 2025, 00:36 EDT
| Prices minimum 15 mins delay
|
Prices in USD
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
$37.48 - $36.18 | |
$60.37 - $29.59 | |
- | |
3,421.48m | |
- | |
- | |
624,510 | |
23.72 | |
821,057.86 | |
-0.01 | |
92.55m | |
US90400D1081 | |
-5.83 | |
- |
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.